Search results
We Think Eurasia Mining (LON:EUA) Can Easily Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
There's a New Drug to Help Prevent COVID. Here's How to Tell If You Need It
Verywell Health via Yahoo News· 2 months agoVerywell / Julie Bang Fact checked by Nick Blackmer Key Takeaways The FDA authorized Pemgarda, a...
Stay Prepared and Stock Up on These At-Home COVID Tests Ahead of the Next Surge
Prevention via Yahoo News· 9 months ago9 Best At-Home COVID Testsabbott, ihealth As COVID-19 variant EG.5, nicknamed “Eris,” continues to...
FDA Recommends the Emergency Authorization of Moderna's COVID-19 Vaccine for Children Ages 6 to 17
Time via Yahoo News· 2 years agoA health worker in London prepares to administer the Moderna COVID-19 vaccine on April 22, 2022....
Health Matters: Here's what you should know about COVID-19 vaccines for children
The State Journal-Register via Yahoo News· 2 years agoTwo weeks ago, a colleague of mine who’s a pediatric doctor, got her 2-year-old son vaccinated for...
Why Shares of InflaRx Are Soaring Wednesday
Motley Fool· 1 year agoShares of InflaRx (NASDAQ: IFRX) were up 48% an hour after the market opened on Wednesday on news the company's COVID-19 therapy was receiving an...
Tory boiler scheme ‘diverts public cash to rich areas’
The Independent via Yahoo News· 2 years agoAn analysis of the government’s £450m Boiler Upgrade Scheme (BUS) suggests taxpayer funds are being...
What Europe’s Energy Crisis Means for Carbon Markets in the Second Half
ETF Trends via Yahoo Finance· 2 years agoAs the energy crisis in Europe intensifies, there has been a lot of speculation and focus on what...
Novavax's Shareholders Can Breathe a Sigh of Relief
Motley Fool· 2 years agoOn the other hand, Novavax finally cleared one of its most important (and long overdue) regulatory milestones. Let's discuss Novavax's recent regulatory...
This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?
Motley Fool· 2 years agoPharmaceutical companies can grab the attention of investors through positive clinical studies and...